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Abstract
Estrogens play an important role in the regulation of placental function, and 17-beta-estradiol (E2)
production rises eighty fold during human pregnancy. Although term placenta has been found to
specifically bind estrogens, cellular localization of estrogen receptor alpha (ER-alpha) in trophoblast
remains unclear. We used western blot analysis and immunohistochemistry with h-151 and ID5
monoclonal antibodies to determine the expression and cellular localization of ER-alpha protein in
human placentae and cultured trophoblast cells. Western blot analysis revealed a ~65 kDa ER-alpha
band in MCF-7 breast carcinoma cells (positive control). A similar band was detected in five normal
term placentae exhibiting strong expression of Thy-1 differentiation protein in the villous core.
However, five other term placentae, which exhibited low or no Thy-1 expression (abnormal
placentae), exhibited virtually no ER-alpha expression. In normal placentae, nuclear ER-alpha
expression was confined to villous cytotrophoblast cells (CT), but syncytiotrophoblast (ST) and
extravillous trophoblast cells were unstained. In abnormal placentae no CT expressing ER-alpha
were detected. Normal and abnormal placentae also showed ER-alpha expression in villous
vascular pericytes and amniotic (but not villous) fibroblasts; no staining was detected in amniotic
epithelial cells or decidual cells. All cultured trophoblast cells derived from the same normal and
abnormal placentae showed distinct ER-alpha expression in western blots, and the ER-alpha
expression was confined to the differentiating CT, but not to the mature ST. Trophoblast cells from
six additional placentae were cultured in normal medium with phenol red (a weak estrogen) as
above (PhR+), or plated in phenol red-free medium (PhR-) without or with mid-pregnancy levels
of E2 (20 nM). Culture in PhR- medium without E2 caused retardation of syncytium formation and
PhR-medium with E2 caused acceleration of syncytium formation compared to cultures in PhR+
medium. These data indicate that the considerable increase in estrogen production during
pregnancy may play a role, via the ER-alpha, in the stimulation of CT differentiation and promote
function in normal placentae. This mechanism, however, may not operate in abnormal placentae,
which show a lack of ER-alpha expression.
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Background
Estrogenic steroids regulate cellular function in a wide va-
riety of tissues [1]. During human pregnancy, the produc-
tion of 17-beta-estradiol (E2) rises eighty fold, from 0.75
nM preovulatory peak to 60 nM at term [2–5], and estro-
gens influence various aspects of placental function and
fetal development in humans and primates [6–12]. Sever-
al previous studies have shown that human placenta
binds estradiol [13–15]. However, more recent immuno-
histochemical studies on paraffin-embedded or snap fro-
zen sections as well as other techniques (RT-PCR for ER-
alpha mRNA) failed to demonstrate estrogen receptor al-
pha (ERα) in human placentae during pregnancy or in
cultures of dispersed placental cells [16,17]. However, it
has been indicated that the failure to detect the ERα does
not entirely preclude the presence of this receptor in hu-
man trophoblast cells, but might be attributed to a rela-
tively low number and density of ERα molecules on these
cells [17]. On the other hand, Billiar et al. reported identi-
fication of the ERα in the nuclei of cultured human pla-
cental syncytiotrophoblast [18]. To our knowledge, no
western blot analysis of placental ERα expression has
been previously described.
During the third trimester, and after 34–36 weeks of preg-
nancy in particular, the placenta may develop an abnor-
mality, often classified as placental aging [19–24]. These
abnormal placentae are characterized by generalized in-
terstitial fibrosis and fibrinoid degeneration of villous
stroma, and are associated with cellular apoptosis and
congestion of villous sinusoids [24–27]. Immunohisto-
chemically, villous abnormality is associated with pro-
gressive diminution of Thy-1 differentiation protein in the
villous core [28]. Marked changes in villous structure are
particularly associated with advanced maternal age
[29,30]. We have recently reported that, with respect to
the Thy-1 expression, compensatory dilatation of villous
sinusoids, and placental expression of low molecular
weight cyclin E variants, the term placentae can be classi-
fied into four placental types (PT1–PT4) [30], where PT4
corresponds to the most severe placental abnormality.
These observations indicate that the term placenta is not a
constant structure, either morphologically or biologically.
Therefore, expression of certain placental proteins, includ-
ing ERα, may vary.
Upon immunohistochemical staining, ERα is predomi-
nantly localized to cell nuclei. However, positive staining
of ERα in the cytoplasm can also be seen [31–33]. It has
been reported that cytoplasmic ERα expression accompa-
nied by a lack of nuclear staining is characteristic for im-
mature cells, nuclear ERα indicates differentiating cells,
and complete lack of ERα expression accompanies termi-
nal differentiation of estrogen-sensitive cells [33]. In addi-
tion, evidence for cell surface ERα expression has been
recently presented [34].
Trophoblast cells are usually separated and grown in me-
dia containing phenol red (PhR) [35]. Phenol red is a
weak estrogen with apparent biological effects, and the
ERα binding affinity in Dulbecco's Modified Eagle's Medi-
um (DMEM) is equivalent to levels of E2 as high as 0.45
nM [36]. Although relatively low when compared to the
E2 levels in pregnancy, this estrogenic binding affinity of
PhR is close to that of E2 during the preovulatory peak
[4,5]. Therefore, we included studies with PhR+, PhR-/E2-
and PhR-/E2+ media in order to determine the effect of es-
trogens on differentiation of cultured trophoblast cells
(syncytium formation) derived from normal and abnor-
mal placental types.
Here we show for the first time that the ERα protein is ex-
pressed in normal and marginally abnormal placentae
(normal placental types) but barely detectable in placen-
tae exhibiting moderate and severe abnormality (abnor-
mal placental types). However, all placental types showed
distinct ERα expression in trophoblast cultures. Nuclear
ERα expression was confined to the villous and tissue cul-
ture mononucleated trophoblast cells, but not syncytio-
trophoblast layers. DMEM with PhR stimulated
differentiation of trophoblast cells from normal placental
types, but mid-pregnancy levels of E2 significantly en-
hanced differentiation of cultured trophoblast cells de-
rived from both normal and abnormal placentae.
Materials and Methods
Tissues
Ten placentae from deliveries between 33 and 41 weeks of
pregnancy were investigated. The source of placental tis-
sue were women with normal and abnormal pregnancies
admitted to the University of Tennessee Medical Center.
Six additional cases were studied for the effect of E2 on
trophoblast differentiation. Excluded were patients with
blood transferable infections, e.g., hepatitis and HIV, and
apparent ascendent placental infections. Frozen tissue
samples of ovarian cancer (a tissue control for ERα expres-
sion) were obtained from NCI Cooperative Human Tissue
Network, Columbus, Ohio. MCF-7 breast carcinoma cells
were maintained as indicated previously [37], and utilized
as a cell culture positive control. Rat kidneys for secondary
antibody absorption were kindly supplied by Dr. Roberto
Dominguez, Laboratory of Biology of Reproduction, Fac-
ultad de Estudios Profesionales Zaragoza, UNAM, Mexico
DF, Mexico. The study was approved by the Institutional
Review Board.
An unusually detailed description of the methods utilized
follows, since placental ERα expression is still a highly
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Tissue processing and peroxidase immunohistochemistry
All chemicals, except where specified otherwise, were pur-
chased from Sigma Chemical Co., St. Louis, MO. The
processing of the placenta started within 30–60 min after
delivery. Several 10 × 10 × 5 mm blocks of tissue were col-
lected from different central cotyledons into cryomold bi-
opsy vinyl specimens molds (Tissue-Tek Cryomold
Biopsy, Miles Inc. Diagnostic Division, Elkhart, IN) and
embedded in an optimum cutting temperature formula-
tion of watersoluble glycols and resins (O.C.T. com-
pound; Miles). The molds with specimens were frozen by
floating on liquid nitrogen and stored at -80°C until use.
Frozen tissues were sliced into 7 µm serial sections using
a cryostat microtome with specimen retraction during re-
turn travel (Carl Zeiss Microm HM 505 E; MICROM
Laborgeräte GmbH, Waldorf, Germany) and ten to twelve
distinct tissue sections were placed on each slide. The
slides were dried ~2 h at room temperature, fixed 5 min in
acetone, dried 30 min, and stored at 4°C until immu-
noperoxidase staining was performed – within two to four
weeks. Prior to staining, the slides were transferred in a
cold room (4°C) into air protected boxes containing Dri-
erite granules (W.A. Hammond Drierite Co, Ltd, Xenia,
OH) to prevent water condensation, and the boxes with
slides were equilibrated to room temperature before
opening.
Slides were incubated overnight (4°C) with affinity puri-
fied mouse anti-human ERα alpha monoclonal antibody
(1:50; 5 µg/ml), clone h-151. This antibody was raised
against a 14 residue synthetic peptide (RAANLWP-
SPLMIKR) based on the human estrogen receptor (resi-
dues 287–300), and reacts specifically with the activated
4S ERα alpha (StressGen Biotechnologies Corp, Victoria,
BC).
Another set of sections was similarly incubated with anti-
human ERα monoclonal antibody (ready to use without
additional dilution), clone ID5 (DAKO Corporation,
Carpinteria, CA). As indicated by DAKO, this antibody re-
acts with the N terminal domain (A/B region) of the ERα
receptor, but the antibody concentration is unknown (not
disclosed by DAKO upon request). In immunoblotting,
this antibody reacts with the ~67 kDa polypeptide chain
obtained by transformation of E. coli and transfection of
COS cells with plasmid vectors expressing ERα [31,32].
We also used monoclonal mouse anti-human Thy-1 anti-
body (1:100; 5 µg/ml), clone F15-42-01 [38] (Dr. Rose-
marie Dalchau of the Institute of Child Health, University
of London, London, England), for the determination of
placental type (PT1–PT4, see below). Control staining
consisted of substitution of primary antibody with PBS, or
with 1:50 diluted (recommended by the vendor) anti-hu-
man CD3 monoclonal antibody, which is directed against
the CD3 pan T cell marker (DAKO). This control staining
was also used, since the CD3 antibody specifically stains
rare fetal T cells in the placental villi only, but not other
villous structures.
After several washes in PBS (room temperature), the sec-
tions were incubated with peroxidase labeled secondary
antibody – goat anti-mouse IgG and IgM, pre-absorbed
with human serum (Jackson Immunoresearch, West
Grove, PA), diluted 1:50 and absorbed with rat kidney ho-
mogenate as described [39]. Tissue sections were proc-
essed further as described previously [40], including
hematoxylin counterstaining of the nuclei.
Evaluation was performed on a Leitz DM RB (Leica Inc.,
Wetzlar, Germany) microscope equipped with differential
interference contrast and a DEI-470 CCD Video Camera
System (Optronics Engineering, Goleta, CA) with detail
enhancement. The video images were captured by CG-7
color frame grabber (Scion Corporation, Frederick, MD)
supported by Scion Image public software developed at
the National Institutes of Health (Wayne Rasband, NIH,
Bethesda, MD), and ported to Windows XP, 2002 release
(Microsoft Corporation, Redmont, WA). To obtain figure
panels, the captured video images were copied into Micro-
soft® Power-Point® 97 SR-2 (Microsoft Corporation). Each
image (including controls) was further copied into Micro-
soft Photo Editor 3.0 (Microsoft Corporation), and total
saturation balanced (usually brightness 45, contrast 65)
and optimized for peroxidase immunohistochemistry by
decreasing the image's blue brightness and contrast (usu-
ally to 45) and blue gamma (usually to 0.83).
For the purpose of statistical analysis in this study, the PT1
and PT2 placentae were coupled, since they can be consid-
ered as normal placentae capable of responding and ful-
filling the demands of the growing fetus by compensatory
villous development or expansion of existing mature villi
[30]. They were compared with placental types showing
moderate and severe abnormality (coupled PT3 and PT4).
Tissue lysates and western blot analysis
For preparation of protein lysates from placental tissue
and ovarian cancer for western blot analysis, including
control Cdk2 and normal rabbit immunoglobulin immu-
noprecipitates (IP), 150 cryostat tissue sections (7µm)
were collected into microcentrifuge tubes and lysed by
adding ice-cold lysis buffer (20 mM Tris pH 7.5, 200 mM
NaCl, 0.25% Nonidet P-40; 400 µl/100 mg of tissue sec-
tions) containing 1 mM sodium orthovanadate, 10 mM
sodium fluoride, and 1 mM phenylmethylsulfonyl fluo-
ride. After 15 min on ice, the lysates were sonicated using
a SonicatorTM Cell Disruptor (Heat Systems-Ultrasonic,
Inc., Plainview, NY) for 5 seconds, and centrifuged at
11000 × g for 20 min at 4°C. Supernatants were stored atReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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minus 80°C. For western blot analysis, protein concentra-
tions were determined by Bradford assay (Bio-Rad, Her-
cules, CA). Equal amounts of unboiled protein (42 µg)
were loaded onto reducing 10% SDS-Tris-glycine polyacr-
ylamide gels, transferred to nitrocellulose (Bio-Rad), and
processed as described previously [41], with some
modifications.
Briefly, two identical membranes were washed in Tris-
buffered saline containing 0.05% Tween 20 (TBST) and
non-specific binding sites were blocked by immersing the
membrane in blocking reagent (0.5% casein in TBST) for
1 hour at room temperature on an orbital shaker. After
blocking, the membranes were briefly rinsed in two
changes of TBST, and washed once for 15 minutes and
twice for 5 minutes in fresh changes of TBST. One of two
identical membranes was first subjected to overnight in-
cubation (4°C) with blocking reagent only (control). An-
other (identical) membrane (second membrane) was
incubated overnight (4°C) for ERα (clone h-151, 0.1 µg/
ml) in blocking reagent. Next the membranes were
washed and incubated with peroxidase labeled secondary
antibody – goat anti-mouse IgG and IgM (Jackson Immu-
noresearch) diluted 1:2000 – for 1 hour at room temper-
ature. Before staining, the secondary antibody was diluted
1:60 (5 µl/300 µl), absorbed with rat kidney homogenate
(150 µg/300 µl) for 20 min, centrifuged and diluted to the
final concentration 1:2000. This absorption eliminated
any non-specific background. After incubation, the mem-
branes were washed 1 × 15 min, 2 × 10 min and 4 × 5 min
in fresh changes of TBST, and incubated for 1 hour in
blocking buffer at room temperature. Bound antibodies
were detected by a chemiluminescent detection system
(ECL; Amersham Pharmacia Biotech, Piscataway, NJ) as
recommended by the manufacturer's protocol. For expo-
sure (1 min, 5 min, and up to 1 h) we used Kodak XAR
film (Eastman Kodak, Rochester, NY).
Next, the membranes were stripped in buffer containing
0.2 M glycine (pH 2.2.), 0.1% SDS, and 1.0% Tween 20
for 45 min, washed, and reprobed with antibodies raised
against other proteins of interest, e.g., the first membrane
with ERα antibody ID5 (DAKO) and the second mem-
brane with actin mouse monoclonal antibody, clone C4
(Boehringer Mannheim Corp., Indianapolis, IN) 0.25 µg/
ml. As indicated above, the ID5 antibody is delivered
ready to use for immunohistochemistry, yet the antibody
concentration is unknown. For western blot analysis we
diluted the ID5 antibody 1:50. Although the ID5 antibody
identified a band similar to that detected by h-151, the
staining was weaker (see Fig. 1). Therefore, higher ID5 an-
tibody concentration might be required for optimum out-
comes in western blot analysis.
Immunoprecipitates (IP)
Cdk2 and rabbit IgG IP were utilized as negative controls
for ERα antibodies. Staining for cyclin E, clone HE12
(PharMingen, San Diego, CA), served as a positive Cdk2
IP control. For Cdk2 IP, the Cdk2 (M2) affinity purified
rabbit polyclonal antibody raised against a peptide map-
ping at the carboxy terminus of Cdk2 of human origin
(Santa Cruz Biotechnology, Santa Cruz, CA) was utilized.
Equal amounts (200 µg) of protein from each sample
were immunoprecipitated with 0.5 µg Cdk2 antibody in
300 µl IP buffer (50 mM Tris, pH 7.5; 5 mM EDTA, 20 mM
glycerol, 150 mM NaCl, 1% NP-40) and 25 µl protein A/
G agarose beads (Santa Cruz Biotechnology) on an orbital
shaker overnight at 4°C.
For IP control, 0.5 µg of normal rabbit IgG was used in-
stead of anti-Cdk2 rabbit polyclonal antibody. Immuno-
precipitates were collected by centrifugation (11000 × g
for 10 min at 4°C), washed three times with 500 µl TG-
buffer containing 20 mM Tris, 250 mM NaCl, and 0.5%
NP-40. For western blot analysis, IP were resuspended in
20 µl 2 × SDS/sample (Laemmli) buffer and the superna-
tants were resolved by SDS-PAGE. Cyclin E variants in
Cdk2 IP were detected by probing with HE12 primary an-
tibody (PharMingen), followed by goat anti-mouse IgG
and IgM (Jackson Immunoresearch) secondary antibody
conjugated with horse radish peroxidase, and visualized
by a chemiluminescent detection system (ECL, Amersham
Pharmacia Biotechnology) and autoradiography as indi-
cated above. Next, the membranes were stripped and
Figure 1
Reactivity of h-151 and ID5 monoclonal antibodies directed 
against human ERα in a western blot with lysates from 
fibroblast culture (FBC), MCF-7 breast carcinoma cells 
(MCF), trophoblast culture (TRC) and ovarian adenocarci-
noma lysates (AOvCa). The h-151 shows a stronger and ID5 
a weaker band at ~65 kDa.
FBC     MCF TRC AOvCa
ID5
h-151
actin
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probed with h-151 ERα antibody as indicated above. In
parallel, the western blots with original protein lysates
were processed – see Fig. 2.
Cell separation & culture
Placental tissue was digested and trophoblast cells isolat-
ed and cultured as described previously [41], with modi-
fications. Since the first digestion yielded only
erythrocytes and some white blood cells and in the second
digestion such cells were accompanied by only rare tro-
phoblast cells, the third supernatant was the first to be col-
lected. The remaining tissue was incubated 30 min at
37°C in 50 ml of normal DMEM (PhR+) containing 25
mM HEPES and 4500 mg/L glucose (DMEM-HG), with-
out trypsin and DNase [42]. The supernatant was collect-
ed and the procedure repeated. Collected cells were
pooled, washed twice in DMEM-HG, diluted to 10 ml in
DMEM-HG supplemented with heat inactivated 5% fetal
bovine serum (FBS; Gibco/BRL) and antibiotics (50 µg/ml
gentamycin, 100 U/ml penicillin, and 100 µg/ml strepto-
mycin), and viable large nucleated cells (95% in trypan
blue exclusion test) were counted. The procedure gave be-
tween 30 – 40 × 106 viable trophoblast cells / 35 g of pla-
cental tissue. Cells were seeded in 60 mm Falcon Primaria
petris (Fisher Scientific, Pittsburgh, PA), in the amount of
7 × 106 per dish cells in 3 ml DMEM-HG with 5% FBS +
antibiotics as above, and cultured in an humidified at-
mosphere with 5% CO2 at 37°C. Cells were harvested for
protein at 16–24 h (early cultures) and at 72 to 96 h (late
cultures). The medium was changed every 24 hours. Dur-
ing cultivation the differentiation of syncytium from cy-
totrophoblast cells was monitored daily, and video
images from several fields were stored in the computer for
additional evaluation and presentation. To prepare cell
lysates, cultures were washed twice with ice-cold PBS,
lysed by adding ice-cold lysis buffer, and stored and proc-
essed for western blot analysis as indicated for tissue
lysates above.
Along with cultures in petri dishes, we established cultures
in LabTek II 4-well glass slides (Nalgene Nunc Interna-
tional, Naperville, Illinois). The slide chambers were pre-
coated with 80 µg/ml of calf skin collagen dissolved in
0.15% NaCl with 50 µg/ml gentamycin. Slides were incu-
bated with 500 µl of collagen solution per chamber for 72
h at 37°C, dried for 2 h in an air flow box, and stored in
the original (UV sterilized and air protected) package at
4°C prior use. The slide chambers were seeded with 4 ×
105 cells per well, and utilized for immunohistochemical
evaluation of ERα expression during trophoblast differen-
tiation (Fig. 4).
Amnion fibroblast cell culture
Amnion was carefully separated from the chorion laeve,
placed into dry petri dishes with epithelium facing the
bottom, allowed to adhere in the incubator for 1 h at
37°C, cut into narrow strips, and incubated for seven to
nine days in the same medium used for trophoblast cul-
tures, with daily monitoring of fibroblast outgrowth. The
amnion was then removed and fibroblasts harvested after
reaching ~80% confluence, and processed for western
blot analysis. Some fibroblasts were passaged as described
for other cell types [37], seeded onto four-chamber slides,
allowed to reach similar confluence, and processed for
immunohistochemistry with primary antibodies to fi-
broblast markers. All cells exhibited staining for Thy-1 fi-
broblast differentiation protein, vimentin and alpha
actin, and no staining with leukocyte common antigen
antibody (negative control) – data not shown.
Quantitative analysis of ERα expression in western blots 
and extent of syncytium formation
Scanned ERα bands from western blots were imported
into the Paint Shop Pro version 5.0 (Jasc Software, Inc.,
Minneapolis, MN), saved in Windows Bitmap, and load-
ed into Scion Image (Scion Corporation). Loaded images
Figure 2
Reactivity of h-151 antibody [ERα (h-151), top row] with 
trophoblast culture (TRC) and ovarian endometrioid carci-
noma (EOvCa) lysates in western blot (WB) and with rabbit 
anti-Cdk2 (lanes 3 and 5) immunoprecipitates (IP). Bottom 
rows show positive control with cyclin E antibody in WB 
(lanes 1 and 2) and Cdk2 IP (lanes 3 and 4). Lane 4 is a nega-
tive control for both antibodies.
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1   2  3    4   5 
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Figure 3
Immunohistochemical detection of ERα in MCF-7 cells and human placenta at term. A proportion of MCF-7 breast carcinoma 
cells show strong nuclear staining with h-151 [A] and ID5 antibodies [B]. [C] No staining of MCF-7 is apparent with control 
(CD3) antibody recognizing human T lymphocytes. [D] In normal placentae, cytotrophoblast cells (c) associated with trophob-
lastic syncytium (s) show strong nuclear staining with ID5 antibody (used for all placental samples stained for the ERα), which 
decreases in cytotrophoblast cells entering the syncytium [E]. [F] CD3 control shows an isolated T cell but no staining of 
other villous structures. Vascular ERα immunoreactivity is not associated with the nuclei of endothelial cells (black arrows, G 
and H). However vascular pericytes (PC and white arrow, H) are strongly stained. [I] In abnormal placentae, the ERα immuno-
reactivity was associated with villous vasculature only. [J] Staining of villous fibroblasts persisting after vascular regression. 
Fibroblasts beneath the amniotic epithelium show ERα staining [K], but no ERα immunoreactivity is apparent in the amniotic 
epithelium [L], extravillous trophoblast (EVT) [M] and decidual cells [N]. [O] Strong Thy-1 staining of decidual cells (right) and 
no staining of EVT (left).
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were enlarged 16 ×, and six 40 square pixel rectangle areas
were measured above (background) and within each
band (crude values). The measurements were copied into
Microsoft Excel 2002 (Microsoft Corporation), and back-
ground values subtracted from crude measurements to
obtain net optical density (O.D.). Net values were utilized
for statistical calculations.
Extent of syncytium formation in PhR and E2 experiments
(see next paragraph) was evaluated by a measurement of
the area occupied by individual clusters. The video images
of clusters in tissue cultures (six representative fields per
time/data point) were saved in Windows Bitmap, and
loaded into Scion Image (Scion Corporation). Individual
clusters were encircled using free hand tool, and the area
of each cluster measured. Clusters exceeding the view area
(90000 sq µm) were evaluated as the maximum area size
Figure 4
ERα immunoreactivity (h-151 antibody) in early (17 h) and late trophoblast cultures (93 h). Dividing cells in [A] exhibit distinct 
surface staining (arrow). Cell in [B] shows moderate cytoplasmic and perinuclear immunoreactivity (arrowhead), and cell in 
[C] exhibits strong nuclear staining without surface expression. [D] Early syncytium shows traces of cytoplasmic ERα staining 
(compare with E). [E] No ERα staining of mature syncytium.
17 h
93 h
17 h
17 h 17 h
20 µm
A A
E E D D
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(90000). Measurements of six clusters were utilized for
statistical evaluation of each culture at a given time.
Effect of PhR and E2 on trophoblast differentiation
Six additional cases were studied for the extent of syncy-
tium formation under various estrogen influences. Cells
were grown in complete DMEM-HG, which contains 45
µM phenol red (PhR+). Phenol red binds to the ERα with
an affinity 0.001% that of E2 (100%) [36]. Hence, the
binding affinity of 45 µM PhR is equivalent to 45 µM × 10-
5, i.e. 0.45 nM E2. Other media were phenol red-free
DMEM-HG without estrogens (PhR-/E2-), or phenol red-
free DMEM-HG with 20 nM E2 (PhR-/E2+). This concen-
tration of E2 corresponds to mid-pregnancy E2 levels [5].
Each medium was supplemented with 5% heat-inactivat-
ed FBS. The PhR-/E2+ medium was prepared as previously
described [37]. Samples were harvested at time 0 (just af-
ter separation of cells), and from the early (16–24 h) and
late cultures (72–96 h).
Statistics
Statistical analysis of data was performed using GraphPad
InStat version 3.01 for Windows software (GraphPad Soft-
ware, San Diego, CA). For evaluation of ERα expression
density, the net O.D. values were transformed (Y = Log
[Y]) and subjected to Kruskal-Wallis Test (Nonparametric
ANOVA), followed by Dunn's Multiple Comparisons
Test. Probability values of P < 0.05 were considered signif-
icant. Area of syncytial aggregates was similarly evaluated.
Results
Control studies – western blot analysis and immunoprecip-
itates (Figures 1 and 2)
Figure 1 shows ERα protein expression at ~65 kDa detect-
ed with two ERα monoclonal antibodies in an amniotic
fibroblast culture (FBC, lane 1), MCF-7 cells (MCF, lane
2) and a trophoblast culture (TRC, lane 3). The last lane is
from an ovarian adenocarcinoma tissue sample (AOvCa).
Since the h-151 antibody clone gave a stronger reaction, it
has been utilized in western blot analysis throughout the
remainder of this study. In Fig. 2, the h-151 antibody
identifies an ERα band in cultured trophoblast cells and
ovarian endometrioid carcinoma (EOvCa) lysates (lanes 1
and 2), but no reactivity is apparent in rabbit anti-Cdk2 IP
(lanes 3 and 5). The HE12 anti-cyclin E antibody was uti-
lized as a positive control for Cdk2 IP. Immunoprecipitate
with normal rabbit immunoglobulin (lane 4) served as a
negative IP control.
Placental types (Table 1)
During the last trimester of human pregnancy, the placen-
ta may exhibit pronounced abnormality associated with
generalized villous degeneration, often called placental
aging or senescence [22–24,27,43–45]. We have recently
shown that placental abnormality is associated with the
diminution of Thy-1 differentiation protein immunos-
taining in the villous core and less or more pronounced
dilatation of villous sinusoids. Based on these two criteria,
accompanied by changes in the expression of cyclin E (cE)
low molecular weight protein variants, four basic placen-
tal types can be recognized (PT1–PT4, Table 1).
Normal mature placentae, placental type 1 (PT1), show
strong Thy-1 expression in the villous core, and relatively
small lumen of sinusoids; expression of cE variants is low.
The PT1 can be viewed as placenta capable of fulfilling the
demands of the growing fetus (occasional villous
regeneration and expansion of existing mature villi),
without requirement of adaptive dilatation of villous
sinusoids.
Table 1: Semi-quantitative correlation of placental types with Thy-1 expression, morphology of villous sinusoids and expression of cyclin 
E low molecular weight variants (cE LMW) for details and quantitative evaluation see Ref. [30], and ERα expression (this study) in 
normal (NP) and abnormal (AP) basic placental categories and placental types (PT1–PT4).
Basic categories Placental types Placental size Dominant villi Villous Thy-1 Dilatation of 
sinusoids
cE LMW variants ERα protein 
expression
NP, ERα+P T 1 a Normal mature high low all low strong
PT2b Normal mature moderate moderate all higher vs. PT1 strong
AP, ERα-P T 3 c Normal aged low excessive some higher traces
PT4Ad Hypertrophy young traces low some higher traces
PT4Be Atrophy immature traces low some higher traces
aPT1, normal placental type, with occasional development of new mature villi or expansion of existing villi to fulfill the demands of the progressively 
growing fetus. Rarely, if there is no requirement for villous replacement or expansion, the ERα might not be expressed. bPT2, marginal irregularity, 
which can be interpreted as a compensation of imminent placental aging by enhanced development of new villi associated with expansion of existing 
mature villi and moderate dilatation of villous sinusoids. cPT3, placental senescence associated with the extreme dilatation of villous blood sinusoids 
and no compensatory villous development or expansion. dPT4A, placental hypertrophy – terminal villi persist in a young/immature state with com-
pensatory development of additional young terminal villi (maternal diabetes mellitus associated with fetal macrosomia). ePT4B, placental atrophy – 
terminal villi persist in a young/immature state without compensatory development of additional young terminal villi (intrauterine growth retarda-
tion and poor Apgars).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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Marginal irregularity, the PT2, is characterized by signifi-
cant diminution of Thy-1 staining, and moderate but sig-
nificant dilatation of villous sinusoids. Cyclin E
expression is highest in this placental type. The PT2 can be
viewed as placentae with villous and vascular adaptation
to imminent placental aging (enhanced villous regenera-
tion and expansion, accompanied by moderate dilatation
of villous sinusoids).
Placentae showing further diminution of Thy-1 expres-
sion and excessive dilatation of villous sinusoids are clas-
sified as PT3. Cyclin E expression is higher compared to
PT1 but lower compared to PT2. The PT3 can be viewed as
placentae exhibiting advanced aging, capable of
compensating demands of the growing fetus only by ex-
treme dilatation of villous blood sinusoids.
Finally, in PT4, Thy-1 expression in terminal villi is very
low, but this is not accompanied by dilatation of villous
sinusoids. Cyclin E expression varies. The PT4 can be
viewed as placentae exhibiting villous immaturity, either
compensated by placental hypertrophy (villous regenera-
tion and expansion without maturation – maternal diabe-
tes mellitus; PT4A), or uncompensated (placental atrophy
associated with villous immaturity – intrauterine growth
retardation; PT4B) with apparent consequences for the
newborn. Further details are given in Ref [30].
Altogether, placental abnormality is not as simple as one
might imagine, e.g. just placental aging. Table 1 shows
that abnormal placentae include either advanced placen-
tal aging with an excess of villous blood sinusoid dilata-
tion (PT3) or severe villous immaturity without
significant dilatation of villous sinusoids (PT4). Again,
the latter can be either compensated by placental hyper-
trophy (normal Apgars associated with fetal macrosomia
in maternal diabetes; PT4A), or uncompensated (placen-
tal hypotrophy) and associated with intrauterine growth
retardation and apparent deterioration of the Apgar scores
[30] (PT4B).
Note that the Table 1 also summarizes the data with re-
spect to ERα expression showing either strong expression
of ERα protein (PT1 and PT2) or only traces (PT3 and
PT4). This supports a view that, regardless of pathophysi-
ology, the intensity of in vivo ERα expression can be
utilized for discrimination between the two basic catego-
ries only, the normal (NP; PT1 and PT2) and the abnor-
mal placentae (AP; PT3 and PT4). Observations
supporting this view follow. Possible exceptions for PT1
are indicated in Table 1 and in discussion.
Placental immunohistochemistry (Figure 3)
Figures 3A and 3B show that h-151 and ID5 anti-ERα an-
tibodies exhibit similar nuclear staining of MCF-7 cells;
no staining in the MCF-7 culture is apparent with control
antibody recognizing CD3 of T cells (Fig. 3C). The immu-
noreactivity of ID5 antibody is shown in Fig. 3D, 3E, and
G-N. In normal placentae, the ERα was strongly expressed
in cytotrophoblast nuclei (c, Fig. 3D) lying beneath tro-
phoblastic syncytium (S), which showed no staining of
the nuclei. Fig. 3E shows that cytotrophoblast cells merg-
ing with the syncytium exhibit a diminution of ERα ex-
pression (compare with 3D). Such occasionally observed
differentiation of cytotrophoblast cells was associated
with weak cytoplasmic staining of the syncytium. Yet the
syncytial nuclei never exerted ERα immunoreactivity (S,
Fig. 4E). Control staining with CD3 antibody (Fig. 3F)
shows an isolated T cell in the villous core, but no staining
of other villous structures. Substitution of primary anti-
body with PBS produced no staining (not shown).
In addition to cytotrophoblast cells, ERα immunoreactiv-
ity was also detected in villous vessels and sinusoids (v).
However, this staining was not associated with the nuclei
of endothelial cells (black arrows, Fig. 3G and 3H), but
with adjacent pericytes (PC and white arrow, Fig. 3H), i.e.
cells originating from placental fibroblasts.
However, cytotrophoblast cells with nuclear ERα immu-
noreactivity were not detected in every placenta investigat-
ed. Fig. 3I shows an abnormal placenta with a lack of ERα
staining except in the villous vessels. Fig. 3J demonstrates
the ERα staining of small (resting) fibroblasts, persisting
after vascular regression in some villi in the placenta
shown in Fig. 3I.
All placentae showed ERα staining of resting fibroblasts
beneath the amniotic epithelium (Fig. 3K), but amniotic
epithelium itself showed no immunoreactivity (Fig. 3L).
Unexpectedly, no ERα immunoreactivity was found in ex-
travillous trophoblast cells and adjacent decidual cells, ei-
ther in chorion laeve (Fig. 3M and 3N) or at the placental
basal plate (not shown). Fig. 3O shows staining for Thy-1
differentiation protein, which allows discrimination be-
tween unstained extravillous trophoblast cells (left) and
Thy-1+ decidual cells (right). Note a lack of Thy-1+ fibrob-
lasts among extravillous trophoblast cells.
Trophoblast cultures (Figure 4)
Figure 4 shows ERα immunoreactivity in early (17 h) and
late (93 h) trophoblast cultures derived from normal pla-
centa. In early cultures, the dividing trophoblast cells ex-
hibited surface ERα expression (arrow, Fig. 4A). Non-
dividing trophoblast cells showed cytoplasmic/perinucle-
ar (arrowhead, Fig. 4B) or perinuclear/nuclear ERα immu-
noreactivity (Fig. 4C). The latter was accompanied by
diminution of cell surface staining. Fig. 4D shows syncy-
tium formation in the early culture, with traces of cyto-
plasmic (white arrowheads, compare with panel 4E) butReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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no nuclear ERα immunoreactivity. Mature syncytia in late
cultures showed no cytoplasmic or nuclear ERα immuno-
reactivity (Fig. 4E). Some late cultures derived from PT2
types showed a mixture of well developed syncytia and
persisting mononucleated trophoblast cells with ERα im-
munoreactivity. However, in late cultures from abnormal
placentae, the formation of syncytia was abortive (see be-
low) and such small syncytia showed regressive changes
and persisting cytoplasmic ERα immunoreactivity (not
shown).
Variability of outcome in trophoblast cultures (Figure 5)
Figures 5 shows that trophoblast cultures from normal
placentae, characterized by strong Thy-1 expression in the
villous core (panel A), exhibit progressive formation of
mid-sized (m) and large syncytial aggregates (l) in early
(EC, panel B) and late cultures (LC, panel C). In contrast,
trophoblast cultures from abnormal placentae, which are
characterized by weak or no Thy-1 expression in the vil-
lous core (panel D), exhibit abortive formation of small
(s) syncytial aggregates (panels E and F).
The ERα expression in normal placentae is high (top of in-
set A), and transformation of cytotrophoblast cells into
the large syncytia (~300 µm in diameter) is accompanied
by ERα diminution (top insets B and C; see also Fig. 4E).
On the other hand, abnormal placentae show almost no
ERα expression in vivo (top inset Fig. 5D). However,
strong ERα expression is apparent in early culture (top in-
set E), and persists thereafter (top inset F), apparently due
to the lack of mature syncytium formation. Bottom insets
show actin expression.
Quantitative evaluation and statistical analysis of ERα ex-
pression in the placentae and trophoblast cultures are
shown in Fig. 5G (error bars indicate SD). Nonparametric
ANOVA was extremely significant (P < 0.0001). Dunn's
Multiple Comparisons Test indicated a significant differ-
ence in ERα expression between normal placenta (PT1 in
vivo) vs. corresponding late culture (PT1 LC), P < 0.01.
Normal placenta (PT1 in vivo) showed significantly high-
er ERα expression when compared to PT4 in vivo (P <
0.001). Trophoblast cultures from PT4 showed a high in-
crease when compared to the PT4 in vivo (P < 0.01) but
there was no significant difference when the PT4 early and
late cultures were compared. However, late PT1 culture
(PT1 LC) showed significantly lower ERα vs. both PT4 cul-
tures (P < 0.05). This correlated with differences in syncy-
tium formation (Fig. 5C vs. 5F).
Variability of placental ERα expression (Figure 6)
In western blot analysis of the ten placental samples inves-
tigated, five showed a distinct ERα band at ~65 kDa and
five exhibited barely detectable ERα expression (Fig. 6A).
Note that in Fig. 6A, the placentae with strong ERα expres-
sion belong to the PT1 (normal) or PT2 (slightly abnor-
mal) types, while placentae with low ERα expression
belong to the PT3 and PT4 types (moderate and severe ab-
normality). For statistical purposes in this study, the PT1
(normal) and PT2 placentae (slightly abnormal with com-
pensatory villous differentiation) were coupled as normal
placentae (NP). The PT3 (moderate abnormality compen-
sated by maximum dilatation of sinusoids) and PT4 pla-
centae (severe abnormality without compensatory
vascular dilatation) were coupled as abnormal placentae
(AP).
Figures 6B and 6C demonstrate ERα expression in early
and late trophoblast cultures. Interestingly, the PT2 in
lane 2 shows a diminution of ERα expression already at
early culture, possibly due to the accelerated syncytium
formation already activated in vivo [30].
Fig. 6D summarizes the data on ERα expression in all ten
placentae and cultures presented in panels 6A-C. It is ap-
parent that high ERα expression in normal placentae in
vivo was relatively constant, yet there were marked differ-
ences among trophoblast cultures, ranging from ERα dim-
inution to persisting ERα expression. Indeed, only a small
proportion of trophoblast cultures from PT2 placentae
showed complete transformation of cytotrophoblast cells
into the syncytia, while in others mature syncytia were ac-
companied by cytotrophoblast cells.
Nonparametric ANOVA for Fig 6D was extremely signifi-
cant (P  < 0.0001). Dunn's Multiple Comparisons Test
indicated significant difference in ERα expression be-
tween NP in vivo when compared to AP in vivo (P < 0.01).
Estrogen receptor alpha expression in AP in vivo was also
significantly lower compared to all other columns at P <
0.001. Interestingly, the ERα expression in AP early and
late cultures significantly exceeded that of NP in vivo (P <
0.001).
Altogether, very low in vivo ERα expression in all moder-
ately and severely abnormal placentae rose significantly
(several fold) in early cultures, and high expression re-
mained unchanged in late cultures. This correlated with
poor development of syncytial aggregates.
The role of E2 in terminal differentiation of trophoblast 
cells (Figures 7 and 8)
Trophoblast cultures from six additional term placentae
were studied for trophoblast differentiation in normal
DMEM-HG medium with phenol red (PhR+), in phenol
red-free medium without E2 (PhR-/E2-), and in phenol
red-free medium with 20 nM E2 (PhR-/E2+). Three pla-
centae were classified as normal (two PT1 and one PT2),
and three as abnormal (two PT3 and one PT4). All time 0
(freshly isolated) trophoblast cells and early culturesReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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Figure 5
A comparison of placental Thy-1 expression (PL in vivo: Thy-1) in normal (PT1, A) and abnormal placentae (PT4, D) and the 
extent of trophoblast differentiation (dashed lines) in early (EC) and late PT1 and PT4 trophoblast cultures (LC). Note that late 
culture from normal placenta shows a large syncytium aggregates (~300 µm in diameter). Abortive formation of syncytium 
clusters (~50 µm) is apparent in late cultures from abnormal placenta. Inserts show ERα (top) and actin bands (bottom) from 
western blots performed from the same cultures. [G] Quantitative evaluation of ERα expression in immunoblots shown in top 
inserts [A-F]. Different column superscripts indicate significant difference. Each column represents 6 measurements. Error 
bars = SD. Details in text.
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Figure 6
Estrogen receptor expression analyzed by western blotting in placental types PT1–PT4 [PL in vivo; A] and corresponding early 
(TRC EC) and late trophoblast cultures (TRC LC) [B and C]. Samples are presented in the order they have been collected. 
[D] Cumulative data on ERα expression in normal (NP in vivo; n = 5) and abnormal placentae (AP in vivo; n = 5) and derived 
early (EC) and late cultures (LC). Different column superscripts indicate significant difference. Each column represents 30 
measurements. Error bars = SD. Details in text.
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Figure 7
Trophoblast differentiation in late cultures from normal (NP; PT1) and abnormal placentae (AP; PT3). Cells were grown in 
complete DMEM-HG, which contains 45 µM phenol red (PhR+), or phenol red-free DMEM-HG without estrogens (PhR-/E2-) 
of with 20 nM E2 (PhR-/E2+). Each medium was supplemented with 5% heat-inactivated FBS. *indicates vesicles and vacuoles 
characteristic of multinucleated syncytiotrophoblast [61]; s, small; m, mid-sized; l, large; xl, extra large syncytial aggregates 
(dashed line). Short arrows = dividing/post-mitotic trophoblasts; long arrow, adjacent trophoblast cells with preservation of 
cell membranes; arrowhead, isolated trophoblast cells. Details in Materials and Methods and in the text.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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showed distinct ERα bands, regardless of the absence (E2-
) or presence of E2 or PhR in the media during trophob-
last separation, and regardless of their origin from normal
or abnormal placentae. Late cultures showed lower ERα
expression in cell lysates from normal placentae when
compared to that from abnormal placentae (data not
shown).
Trophoblast cells from normal placentae cultured in PhR+
medium formed mid-sized syncytial clusters in early cul-
tures and large syncytial clusters in late cultures (l, Fig. 7A,
see also Fig. 5B and 5C). The same cells cultured in PhR-/
E2- medium showed a retardation of syncytium forma-
tion in early and late cultures, where they did not exceed
clusters of small size (s, Fig. 7B). Trophoblast cells divided
(short arrows) and associated together, yet often without
fusing (long arrow, Fig 7B). However, PhR-/E2+ medium
caused marked acceleration of trophoblast differentiation
in early cultures, where the syncytial clusters already
reached a large size. In addition, late cultures showed
formation of extremely large syncytial aggregates (xl, Fig.
7C).
Trophoblast cells from abnormal placentae (AP) cultured
in PhR+ medium formed small syncytial clusters in early
cultures and rare mid-sized clusters in late cultures (m,
Figure 8
Mean area (square µm + SD) of syncytial aggregates in late cultures of trophoblast cells derived from normal (NP) and abnor-
mal placentae (AP). Cells were grown as indicated in Materials and Methods – see also Fig. 7 for details and abbreviations. Each 
column represents eighteen measurements. Different column superscripts indicate significant difference.
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Fig. 7D, see also Fig. 5E and 5F). The same cells cultured
in PhR-/E2- medium showed severe retardation of syncy-
tium formation in early and late cultures (Fig. 7E). How-
ever, PhR-/E2+ medium stimulated trophoblast
differentiation in early and late cultures, where syncytial
aggregates reached a large size (Fig. 7F).
Fig. 8 summarizes the data on the extent of syncytium for-
mation in late trophoblast cultures from three NP and
three AP studied. It is apparent that PhR+ media stimulat-
ed syncytium formation in NP but not AP. Lack of estro-
gens (PhR-/E2-) caused retardation and E2
supplementation stimulated syncytium formation in tro-
phoblast cultures derived from both normal and abnor-
mal placentae.
Nonparametric ANOVA for Fig 8 was extremely significant
(P < 0.0001). Dunn's Multiple Comparisons Test indicat-
ed significant differences in ERα expression at P < 0.01 as
indicated by different column superscripts in Fig. 8. Note
that the measurement of extra large syncytium aggregates
in NP PhR-/E2+ (see xl, Fig. 7C) was limited by a maxi-
mum view area representing 90000 sq µm (see Materials
and Methods).
Altogether, E2 appears to stimulate terminal differentia-
tion of trophoblast cells derived from normal and abnor-
mal placentae (both expressing ERα in vitro) and to
enhance a fusion of syncytial clusters into extremely large
aggregates. The presence of phenol red, a weak estrogen,
in the culture is sufficient to stimulate differentiation of
trophoblast cells into large syncytia in cultures from nor-
mal placentae, but not from abnormal ones.
Discussion
This is the first demonstration of ERα protein expression
in human placentae by western blot analysis. Nuclear ERα
expression was confined to the villous mononucleated
trophoblast cells associated with trophoblastic syncytium
and differentiating cultured cytotrophoblast cells. No nu-
clear ERα staining was detected in trophoblastic syncytia
in vivo or in vitro. Unexpectedly, extravillous trophoblast
cells also lacked ERα. These observations indicate that
trophoblastic nuclear ERα expression is characteristic of
cytotrophoblast cells differentiating into syncytial struc-
tures, but not for resting cytotrophoblast cells. Additional
placental cell types expressing the ERα were fibroblast-de-
rived vascular pericytes and extravillous (amniotic) fi-
broblasts. Estrogens may, via the ERα, contribute to the
stimulation of terminal differentiation of mononucleated
trophoblast cells into syncytial aggregates. Terminal tro-
phoblast differentiation is associated with diminution of
ERα expression.
Nuclear ERα expression is characteristic of estrogen-sensi-
tive cells, which might be stimulated by estrogens to pro-
liferate as well as modulate differentiated functions. In
placental material ERα expression determined by western
blot analysis showed either strong ERα or barely detecta-
ble ERα bands, and where investigated, there were no
transitions between these two types of ERα expression. In
addition, strong ERα expression was associated with nor-
mal placentae (PT1 and PT2), suggesting that in these
term pregnancies ERα+ cytotrophoblast cells contribute to
syncytium differentiation. On the other hand, placentae
exhibiting moderate and severe abnormality showed vir-
tually no ERα expression by western blot analysis or im-
munohistochemical staining of tissue sections (except the
vessels). This indicates there is no syncytium differentia-
tion, although the senescent placentae of females of ad-
vanced maternal age were reported to exhibit a higher
number of Ki-67 (dividing) mononuclear trophoblast
cells [29]. These observations suggest that dividing cy-
totrophoblast cells do not necessarily contribute to syncy-
tium differentiation and may not express ERα.
An unexpected feature was the strong ERα expression of
cultured trophoblast cells derived from placentae defi-
cient in ERα expression in vivo. This observation indicates
that the lack of ERα expression in vivo is not due to the in-
ability of trophoblast cells to express ERα in general. It
might be speculated that under conditions of tissue cul-
ture factors modulating ERα expression are different from
that in vivo. Given that ERα expression is already
enhanced at the end of the cell separation (time 0), ERα
expression appears to be inhibited in vivo.
Table 2: Summary of observations on normal (NP) and abnormal placentae (AP) and derived trophoblast cultures: ERα expression in 
vivo and in vitro, and formation of large syncytial aggregates in late trophoblast cultures under PhR+, PhR-/E2- and PhR-/E2+ conditions.
Condition NP AP
ERα expression in vivo + -
in vitro + +
Large syncytial aggregates PhR+ + -
PhR-/E2- - -
PhR-/E2+ ++* +
* Extra large syncytial aggregatesReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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Virtual lack of in vivo ERα expression seems to be an ad-
ditional indicator of moderate and severe placental ab-
normality. Based on in vivo ERα expression, the placentae
may be divided into the two basic categories, normal pla-
centae: NP, ERα+, and abnormal placentae: AP, ERα-.
However, it should be considered that some PT1 placen-
tae, the functions of which are in harmony with actual fe-
tal demands, may not exhibit compensatory
differentiation of trophoblast cells and, therefore, may
not express ERα in vivo (Table 1). The existence of placen-
tal aging is still debated, yet various clinical, morphologi-
cal, cellular and molecular aspects of placental senescence
have been indicated [20,21,24,25,27–30,45–47]. Howev-
er, it is still unclear if there are any consequences of pla-
cental aging for normal pregnancy, delivery, and neonatal
birth weight and Apgar scores [29,48,49]. It has to be not-
ed that even the abnormal placenta may have the capacity
to improve its function and compensate for demands of
the growing fetus, e.g., by elongation and excessive dilata-
tion of villous sinusoids [26,50].
As recently indicated [30], certain types of placental ab-
normality have also been ascribed to the villous immatu-
rity (low or no Thy-1 differentiation protein expression in
placental villi and a lack of blood sinusoid dilatation –
PT4, see above) accompanied by an existing (diabetes
mellitus) or absent placental hypertrophy (intrauterine
growth retardation) – Table 1. However, it has been sug-
gested that although chronic placental adaptations may
be successful for the fetal survival, e.g. in placental senes-
cence or maternal diabetes, they may lead to adverse out-
comes later in the life of an individual [22]. Therefore,
although it might not be apparent in the newborn, the ab-
normal placenta may indicate a burden for the future of
an individual and for the quality of the human popula-
tion. Yet, placental abnormality is not a rare event, since it
has been found in 50% of the cases in our material.
The second cell type expressing the ERα were amniotic fi-
broblasts and fibroblast-derived vascular pericytes. Estro-
gen receptors have been identified in cultured fibroblasts
of various origins and vascular smooth muscle cells [51–
53]. Estrogens enhance proliferation of fibroblasts and in-
hibit vascular smooth muscle migration [54,55]. Binding
of estrogens to fibroblasts also stimulates fibroblast inter-
action with epithelial cells with subsequent acceleration
of maturation of epithelial cells [56].
The last observation is of particular importance to several
aspects of this study. Activated Thy-1+ villous fibroblasts,
characterized by secretion of Thy-1 differentiation protein
among epithelial cells in vivo and among cultured tro-
phoblast cells in vitro [57,58], are present in PT1 and PT2,
but absent from PT3 and PT4 placentae [30] (see also Fig.
5A vs. 5D). Various types of placental mesenchymal cells
inevitably accompany "purified" trophoblast cells [41],
and highly activated Thy-1+ fibroblasts are present in
early trophoblast cultures [58]. Extravillous trophoblast
cells do not express ERα, yet indeed, there are no Thy-1+
fibroblasts among the basal plate and chorion laeve ex-
travillous trophoblast cells (see Fig. 3O). Hence, Thy-1+
fibroblasts may stimulate differentiation and ERα expres-
sion in mononucleated trophoblast cells.
Although estrogens were suspected to stimulate trophob-
last differentiation [12,59], no direct proof has been pro-
vided up to date. Trophoblast cells derived from normal
placentae differentiated into large syncytial clusters in the
presence of PhR without E2 supplementation. Phenol red
in tissue culture media is a weak estrogen, sufficient to
stimulate the proliferation of ERα+ MCF-7 human breast
carcinoma cells [36]. We report a similar estrogenic effect
of PhR+ media on trophoblast differentiation and syncy-
tium formation in cultures from normal placentae, but
not from abnormal ones.
Because trophoblast cultures derived from both the nor-
mal and abnormal placentae were ERα+ in time 0 cell
lysates, the above difference can not be ascribed to the
lack of ERα expression. Yet, ERα at mid-pregnancy levels
further stimulated syncytium development, as evidenced
by the development of extremely large syncytial aggre-
gates in late cultures from normal placentae, and develop-
ment of large syncytial aggregates in cultures from
abnormal placentae. Hence, trophoblast cells from abnor-
mal placentae are also capable of differentiating in re-
sponse to estrogenic stimuli, but the level of estrogens
must be higher. However, it is important to note that
pharmacological levels of E2 (200 nM) have been found
to suppress development of syncytial aggregates even in
cultures derived from normal placentae (unpublished da-
ta). Hence, either low or extremely high levels of estrogens
in vivo may cause a suppression of placental syncytium
formation.
Our observations indicate that the cultures from normal
and abnormal placentae contain similar trophoblast cells
capable of differentiating in response to exogenous estro-
gens, but they may differ in the ability of accompanying
mesenchymal cells to promote this process. One might
speculate that in cultures derived from normal placentae,
the weak estrogenic effect of PhR is sufficient to stimulate
trophoblast/mesenchymal cell interactions in vitro
resulting in a local production of estrogens. It is possible
that the estrogens can be secreted by the syncytiotrophob-
last clusters and fibroblasts, because these cell types ex-
press the enzyme aromatase [60]. Indeed, trophoblast
cultures are capable of producing estrogens [35].Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/13
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The data are summarized in Table 2. Our observations rise
a fundamental question if E2 is not, in fact, an essential
input for trophoblast differentiation. Yet, previous experi-
ence has shown that lower estrogen levels during pregnan-
cy are indicative of poor fetal condition [5].
Conclusion
Placental ERα expression in vivo is high in normal placen-
tae and barely detectable in abnormal placentae. The sig-
nificant increase of estrogen production occurring with
pregnancy advancement may play a role, via the ERα, in
the stimulation of terminal differentiation of mononucle-
ated trophoblast cells into syncytial aggregates and pro-
mote placental function. This mechanism, however, may
not operate in abnormal placentae, which show a lack of
ERα expression.
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